|
|
|
| Clinical Effect of Anlotinib Capsules Combined with Immune First-line Maintenance Treatment for Extensive Stage-small Cell Lung Carcinoma |
| XIONG Xin |
| First-author's address: Department of Oncology Ⅱ, Jiangxi Chest Hospital, Nanchang 330006, China |
|
|
|
|
|
|
Received: 08 November 2023
|
|
|
|
|
|
|
